Newron Pharmaceuticals S.p.A. (SWX:NWRN)
Switzerland · Delayed Price · Currency is CHF 22.90
+0.60 (2.69%)
At close: Dec 19, 2025
Newron Pharmaceuticals Market Cap
Newron Pharmaceuticals has a market cap or net worth of 457.11 million as of December 19, 2025. Its market cap has increased by 209.09% in one year.
Market Cap
457.11M
Enterprise Value
465.86M
Revenue
55.93M
Ranking
n/a
PE Ratio
20.60
Stock Price
22.90
Market Cap Chart
Since December 12, 2006, Newron Pharmaceuticals's market cap has increased from 309.05M to 457.11M, an increase of 47.91%. That is a compound annual growth rate of 2.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 457.11M | 162.47% |
| Dec 30, 2024 | 174.16M | 97.16% |
| Dec 29, 2023 | 88.33M | 219.35% |
| Dec 30, 2022 | 27.66M | -4.32% |
| Dec 30, 2021 | 28.91M | -24.65% |
| Dec 30, 2020 | 38.37M | -66.14% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 273.36B |
| Novartis AG | 206.73B |
| Galderma Group AG | 39.12B |
| Lonza Group AG | 37.24B |
| Alcon | 31.28B |
| Sandoz Group AG | 25.02B |
| Straumann Holding AG | 15.06B |
| Sonova Holding AG | 12.31B |